Not sure what it should trade at but given they are anticipated to be EBITDA negative FY22 and flat FY23 and growing FY24 I think a lot of investors will see this as too long away for their current money to be invested into a company that will not be profitable.
That being said, I thought the results were good given the situation isn't normal. With a normal world I'd like to see revenues for their COVID related products and see if they drop drastically or maintain. I see their other product offerings as very good in a normal world as they provide the insight many companies need.
Not sure what it should trade at but given they are anticipated...
Add BEO (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
2.1¢ |
Change
-0.002(8.70%) |
Mkt cap ! $10.25M | |||
| Open | High | Low | Value | Volume |
| 2.1¢ | 2.1¢ | 2.1¢ | $2.626K | 125.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 183520 | 2.1¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 2.3¢ | 300155 | 1 |
View Market Depth
| Last trade - 12.26pm 29/08/2024 (20 minute delay) ? |
| BEO (ASX) Chart |